A SINGLE CENTER, OPEN LABEL, FIXED SEQUENCE STUDY TO INVESTIGATE THE EFFECT OF MULTIPLE DOSE BITOPERTIN ON SINGLE DOSE PHARMACOKINETICS OF MIDAZOLAM IN HEALTHY VOLUNTEERS
Withdrawn prior to enrolment
Phase of Trial: Phase I
Latest Information Update: 27 Oct 2017
At a glance
- Drugs Bitopertin (Primary) ; Midazolam
- Indications Obsessive-compulsive disorders; Schizophrenia
- Focus Pharmacokinetics
- Sponsors Roche
- 14 Oct 2014 Status changed from not yet recruiting to withdrawn prior to enrolment, as per ClinicalTrials.gov record.
- 27 Jan 2014 Planned End Date changed from 1 Feb 2014 to 1 Mar 2014 as per ClinicalTrials.gov record.
- 27 Jan 2014 Planned initiation date changed from 1 Jan 2014 to 1 Feb 2014 as per ClinicalTrials.gov record.